Accumulation of AGO2 Facilitates Tumorigenesis of Human Hepatocellular Carcinoma

Figure 1

Clinical analysis of AGO2 expression in hepatocellular carcinoma patients. (a) Representative image of AGO2 IHC staining in noncancerous (epithelium) tissues and HCC tissues. (b) Relative expression levels of AGO2 in noncancerous and HCC tissues were determined by measuring the staining intensity (ratings: 0, 1, 2, and 3). Values represented as the (). Kaplan-Meier survival analysis according to AGO2 expression (c), age (d), gender (e), and tumor size (f) in 90 patients with HCC (log-rank test). Probability of survival of patients: (c) low expression of AGO2 () vs. overexpression of AGO2 () (); (d) () vs. () (); (e) male () vs. female () (); (f) () vs. () ().

(a)

(b)

(c)

(d)

(e)

(f)